Table 3.

Genotypes distribution in laryngeal cancer case group and control group. alleles distribution in laryngeal cancer case group and control group.

(a) DIAPH2 PTPRD HICI.
	AT	AA	TT	TT	AT	AA	CT	TT	CC
Case	23–8.6%	49–18.4%	195–73.0%	133–49.8%	103–38.6%	31–11.6%	123–46.1%	107–40.1%	37–13.8%
Control	48–30.6%	17–10.8%	92–58.6%	79–50.3%	65–41.4%	13–8.3%	63–40.1%	71–45.2%	23–14.6%
(b) DIAPH2 PTPRD HICI.
	A		T	T	A		C	T
Case	101–18.9%		413–81.1%	369–69.1%	165–30.9%		197–36.9%	337–3.11%
Control	82–26.1%		184–73.9%	223–71.0 %	81–29.0%		109–34.7 %	205–65.3%

(a) significant difference in rs6620138 DIAPH2 distribution between case and control (chi-square test—p < 0.001). (b) significance difference in DIAPH2 (rs6620138) distribution between case and control (chi-square test—p < 0.001), no other.